World Mitochondrial Disease Week 2024

During the week, Abliva will share videos focused on the disease, the important role that patients play in drug development, and the company’s own drug development programs. Abliva will also talk about the positive readout of the interim analysis of the FALCON study, a potentially registrational study evaluating the safety and efficacy of KL1333 in adult mitochondrial disease patients who experience debilitating fatigue and muscle weakness.

Starting 16 September, Abliva’s videos will be posted daily on YouTube, LinkedIn, and below.

16 Sep: Join Abliva for World Mitochondrial Disease Week – Meet Regina

17 Sep: Designing Therapies for Mitochondrial Disease: About Abliva’s NV354

18 Sep: Introducing the FALCON study: Meet Dag Nesse – Abliva’s VP Clinical Operations

19 Sep: Developing the PROMIS® Fatigue Mitochondrial Disease Short Form: Meet Magnus Hansson – Abliva’s Chief Medical Officer

20 Sep: CEO, Ellen Donnelly, interviewed by BioStock on the FALCON interim analysis

21 Sep: Abliva ‘Lights Up for Mito’ during World Mitochondrial Disease Week

22 Sep: Inheritance of mitochondrial disease – Meet Regina, whose daughters do not want to have children

World Mitochondrial Disease Week 2023

World Mitochondrial Disease Week 2023 takes place on September 18 – 24, this year with the theme: fatigue. The week aims to increase global awareness and understanding of the disease.

Event

World Mitochondrial Disease Week 2022

World Mitochondrial Disease Week is an initiative of International Mito Patients (IMP). The purpose of the World Mitochondrial Disease Week is to raise awareness of mitochondrial disease (mito) on a global scale through educational, fundraising and advocacy activities. This year on 18 – 24 September.